Literature DB >> 16819543

Personality traits and cancer survival: a Danish cohort study.

N Nakaya1, P E Hansen, I R Schapiro, L F Eplov, K Saito-Nakaya, Y Uchitomi, C Johansen.   

Abstract

We conducted a population-based prospective cohort study in Denmark to investigate associations between the personality traits and cancer survival. Between 1976 and 1977, 1020 residents of the Copenhagen County completed a questionnaire eliciting information on personality traits and various health habits. The personality traits extraversion and neuroticism were measured using the short form of the Eysenck Personality Inventory. Follow-up in the Danish Cancer Registry for 1976-2002 revealed 189 incidents of primary cancer and follow-up for death from the date of the cancer diagnosis until 2005 revealed 82 deaths from all-cause in this group. A Cox proportional-hazards model was used to estimate the hazard ratios (HRs) of death from all-cause according to extraversion and neuroticism adjusting for potential confounding factors. A significant association was found between neuroticism and risk of death (HR, 2.3 (95% CI=1.1-4.7); Linear trend P=0.04) but not between extraversion and risk of death (HR, 0.9 (0.4-1.7); Linear trend P=0.34). Similar results were found when using cancer-related death. Stratification by gender revealed a strong positive association between neuroticism and the risk of death among women (Linear trend P=0.03). This study showed that neuroticism is negatively [corrected] associated with cancer survival. Further research on neuroticism and cancer survival is needed.

Entities:  

Mesh:

Year:  2006        PMID: 16819543      PMCID: PMC2360615          DOI: 10.1038/sj.bjc.6603244

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


Psychological traits may alter immune and endocrine function and it has long been hypothesised that, through this pathway, personality traits may affect cancer incidence and survival (Spiegel and Kato, 1996; Kiecolt-Glaser and Glaser, 1999; Dalton ). The results of our earlier prospective cohort studies, however, do not support the hypothesis that personality traits measured by the Eysenck questionnaire are associated with risk for cancer (Schapiro ; Nakaya ; Hansen ). The role of personality traits in cancer survival has been controversial. Five studies have investigated associations between personality traits and cancer survival. Two studies found statistically significant associations (Hislop ; Ratcliffe ) but three other studies found no association between personality traits and risk of death in cancer patients (Greer ; Dean and Surtees, 1989; Nakaya ). However, four studies had several limitations, including failure to control for cigarette smoking or alcohol consumption, and failing to assess personality traits before the cancer diagnosis (Greer ; Hislop ; Dean and Surtees, 1989; Ratcliffe ). We conducted a population-based prospective cohort study in Denmark to further investigate associations between the personality traits and cancer survival. This study focused on personality traits measured before the cancer diagnosis, and the study to our knowledge included the second highest number of cancer cases and deaths of the studies conducted until now.

MATERIALS AND METHODS

Study cohort

All persons born 1936 and living in four municipalities in a suburban area of Copenhagen in 1976 (n=1198 persons) were invited to participate in an epidemiologic health survey at the Glostrup Population Studies. The survey included a social-psychiatric interview (Hollnagel ). Of these, 1052 persons (88%), equally distributed by sex, accepted the invitation. In a study, the study population was found to be representative of the age group 40 years in Copenhagen County (Hollnagel ).

Assessment of personality traits and other characteristics

The social-psychiatric interview lasted approximately 1 h and was performed by a physician. The questionnaire included marital status, socioeconomic status, smoking habits, alcohol consumption, personality, and the presence of symptoms of a psychiatric disease as evaluated by the interviewing doctor (Sælan and Garde, 1979). Personality traits were measured using a short form of the Eysenck Personality Inventory (EPI-Q) (Eysenck and Eysenck, 1965) consisting of 18 items (Floderus, 1974). This abbreviated version, the EPI-Q allows measurement of two dimensions: degree of extraversion and degree of neuroticism (Schapiro ). Extraversion represents sociability, liveliness, and surgency and neuroticism represents emotional instability, and anxiousness (Eysenck and Eysenck, 1975).

Linkage to registries

Data on all members of the study population were linked to the Central Population Register for verification of the personal identification number and for information on vital statistics and migration. The Central Population Register in Denmark was established on 1 April 1968, and all Danish residents are assigned a 10-digit personal identification number, which incorporates sex and date of birth and permits accurate linkage of information among registries. Subsequently, the study cohort was linked to the Danish Cancer Registry, which began reporting cancer incidence on a nationwide scale in 1943. Each record includes the personal identification number, date of diagnosis of the tumor, and information on the tumor. Tumors are coded according to a modified Danish version of the International Classification of Diseases, Seventh Revision (Jensen ). Finally, the study cohort was linked to the Danish Registry of Causes of Death, which holds individual records of deaths in Denmark from 1943 and onwards (Juel and Helweg-Larsen, 1999). Cause of death was coded according to a modified Danish version of the International Classification of Diseases, Tenth Revision.

Follow-up

From the 1052 persons in the study, we excluded 21 persons who had foreign citizenship as well as persons who had not completed the extraversion and neuroticism scales leaving 1020 persons. Members of the cohort were followed for cancer from the date of social-psychiatric interview, until the date of first cancer (other than non-melanoma skin cancer), date of emigration, date of death, or 31 December 2002. This resulted in a total of 189 cancer cases left for analysis and this subcohort was then followed-up for death from the date of the cancer diagnosis until date of emigration, date of death, or the end of the study period (31 January 2005). The 189 cancer cases (65 men and 124 women) of this study accrued approximately 1704 person-years of follow-up, with an average of 6 years. A total of 82 deaths from all causes (37 men and 45 women) were observed during follow-up. 84% of the deaths observed were cancer related, 16% were related to other causes. No deaths were classified as suicide.

Statistical analysis

The objective of the current analyses was to determine the effect of extroversion and neuroticism on cancer survival. The personality subscales were included both as linear as well as ordinal variables. When using them as ordinal variables the scores on each personality subscale (score 0–9) were divided into three score levels approximately equal in size and as a result, the cutoff scores vary with the subscale. Hazard ratios (HRs) were computed as the death rate among subjects in each personality score level divided by the death rate among subjects in the lowest score level. A Cox proportional-hazard model was used to estimate HRs for extraversion and neuroticism. We used the SAS PHREG procedure in the SAS version 8.2 statistical software package (Cary, NC, USA) (Rothman and Greenland, 1998). All P-values were two-tailed. First, we tested which of a number of potential demographic and medical factors to include as confounding variables in the analyses. Then we performed univariate analyses (adjusted for sex and age at cancer diagnosis), as well as multivariate analyses (adjusted for potential confounders shown to have a statistically significant effect on survival). In addition to sex and age at cancer diagnosis (continuous variable), we considered the following variables as a priori confounders: cancer site (digestive organs, hormone-related organs, virus and immune-related organs, respiratory organs, or other organs) (World Health Organization, 1992; Schapiro ); clinical stage (in situ, localised, regional invasion, distant metastasis, or unknown); length of education in years (<10, or >10); marital status (living with spouse, or living without spouse); social class (I–II, III–IV, or V); smoking status at baseline (never smokers, past smokers, or current smokers); alcohol consumption in grams of alcohol per week at baseline (0, 1–150 or 151 or more); and psychiatric status at time of interview (normal, neurotic, or deviant/psychotic). The social class variable was based on a classification constructed by the Social Research Institute in Denmark and is based on a combination of information on ownership of land, education, employment status, and number of subordinates. Social group I is the highest social group. The alcohol consumption variable was computed using the following definitions: one glass of beer or one glass of wine amounts to 12 g of alcohol, one glass of schnapps or other liqueur amounts to 9 g of alcohol. To test if there was a dose–response relationship between the personality subscales and cancer survival we did trend tests using the personality subscales as linear variables. We also investigated whether undiagnosed cancer could influence the personality scores by excluding persons diagnosed with cancer within the first 3 years. To investigate if other causes of death beside cancer could influence the results, analyses were performed on death from all causes as well as on death from cancer exclusively. We tested possible effect modifications of sex in order to investigate if personality traits have different effects among men and women. These tests of effect modification were performed by including an interaction term for sex and neuroticism in the analysis. We conducted stratified analyses according to 10-year age groups to investigate whether an effect of personality could be related to a specific age group. Finally, we did analyses where the personality scales were divided into four levels based on quartiles in order to test if changing the cutoff points would make a difference in the size of effect.

RESULTS

First, we compared the characteristics of persons according to extraversion and neuroticism. Persons who scored high on extraversion were more likely to be male (P<0.01), current smokers at baseline (P=0.02), and consumers of alcohol at baseline (P<0.01). Persons who scored high on neuroticism were less likely to be male (P=0.03) and living with their spouse (P=0.01) and more likely to be described as neurotic in their psychiatric status (P<0.01) (Table 1).
Table 1

Demographic and medical characteristics according to extraversion and neuroticism in 189 persons diagnosed with cancer

  Extraversion
  Neuroticism
 
Characteristics ⩽3 4–6 ⩾7 P-value ⩽2 3–4 ⩾5 P-value
No. of subjects597753 815949 
Age in years at cancer diagnosis, mean±s.d.55±854±856±70.3855±855±854±80.88
         
Sex (%)   <0.01   0.03
 Man203353 443123 
 Woman806847 567078 
         
Cancer type (%)   0.72    
 Digestive organs (excluding liver)12106 99120.91
 Hormone-related organsa242113 201723 
 Virus and immune-related organsb444347 425339 
 Respiratory organs101013 14910 
 Other organs101621 161416 
         
Clinical stage (%)   0.69   0.11
In situ14169 111712 
 Localised424047 374649 
 Regional invasion31013 1536 
 Distant metastasis171313 20146 
 Unknown242117 172027 
         
Length of education in years (%)   0.60   0.71
 <10757179 727678 
 ⩾10252921 282423 
         
Marital status, living with spouse (%)   0.83   0.01
 Yes858887 889576 
 No151213 12825 
         
Social classc (%)   0.12   0.07
 I, II191628 271910 
 III, IV285857 516153 
 V342615 222037 
         
Smoking status at baseline (%)   0.02   0.48
 Never smokers462623 352533 
 Past smokers15109 15108 
 Current smokers396468 516459 
         
Alcohol consumption at baseline (g week1) (%)   <0.01   0.21
 0312113 192424 
 1–150586451 604965 
 ⩾151121636 212710 
         
Psychiatric status d        <0.01
 Normal8182890.70969055 
 Neurotic15168 1839 
 Deviant/psychotic334 226 

Including cancers of the breast, corpus uteri, ovary, and prostate.

Including cancers of the skin, non-Hodgkin's lymphoma, Hodgkin's disease, leukaemia, liver cancer, and cancer of the cervix uteri.

The social class variable is based on a classification constructed by the Social Research Institute in Denmark and is based on a combination of information on ownership of land, education, employment status, and number of subordinates. Social group I is the highest social group.

As evaluated by the physician who conducted the social-psychiatric interview.

In the univariate Cox proportional-hazard regression analyses, the following six of ten demographic and medical variables were significantly associated with cancer survival compared with each referent category (category that showed increased risk); age in years at cancer diagnosis (continuous variables), sex (man), cancer site (virus and immune-related organs or respiratory organs), clinical stage (in situ, regional invasion, distant metastasis, or unknown), smoking status (past smokers or current smokers), and alcohol consumption (⩾151 g week−1) (Table 2). Subjects described as neurotic in their psychiatric status showed an increased and borderline significant (P=0.053) risk of death from all causes compared to normal subjects. Being a theoretically interesting and borderline significant risk factor for death of all causes, we decided to include it in the further analyses.
Table 2

Hazard ratios (HRs) for death from all causes and 95% confidence intervals (CIs) according to demographic and medical characteristics in 189 persons diagnosed with cancer

     Univariate analysis
Characteristics No. of subjects Median survival years No. of cases HR (95%CI)a P-value
Age in years at cancer diagnosis
 Continuous variable1896821.05 (1.02–1.08)<0.01
      
Sex
 Man653372.0 (1.3–3.0)<0.01
 Woman1249451.0 (referent) 
      
Cancer type (%)
 Digestive organs (excluding liver)18491.0 (referent) 
 Hormone-related organsb375150.7 (0.3–1.5)0.33
 Virus and immune-related organsc8412210.4 (0.2–0.8)0.01
 Respiratory organs211183.7 (1.7–8.4)<0.01
 Other organs293191.5 (0.7–3.3)0.31
      
Clinical stage (%)
In situ252631.0 (referent) 
 Localised817244.1 (1.2–14.2)0.02
 Regional invasion1711118.2 (4.9–68.1)<0.01
 Distant metastasis2702752.5 (14.9–185.1)<0.01
 Unknown396176.7 (1.9–23.9)<0.01
      
Educational periods in years (%)
 <101416651.3 (0.8–2.3)0.28
 ⩾10487171.0 (referent) 
      
Marital status, living with spouse (%)
 Yes1646711.0 (referent) 
 No255110.9 (0.5–1.6)0.64
      
Social class (%)
 I, II384151.0 (referent) 
 III, IV1037441.0 (0.6–1.9)0.90
 V487231.2 (0.6–2.3)0.57
      
Smoking status at baseline (%)
 Never smokers599151.0 (referent) 
 Past smokers224112.4 (1.1–5.3)0.02
 Current smokers1084562.6 (1.4–4.5)<0.01
      
Alcohol consumption at baseline (g week1) (%)
 0417151.0 (referent) 
 1–1501107441.1 (0.6–1.9)0.82
 ⩾151383232.0 (1.0–3.8)0.04
      
Psychiatric status d
 Normal1586651.0 (referent) 
 Neurotic253151.7 (1.0–3.0)0.053
 Deviant/psychotic6620.7 (0.2–2.9)0.64

All hazard ratios (HRs) are given with 95% confidence intervals (CIs) in parentheses.

Including cancers of the breast, corpus uteri, ovary, and prostate.

Including cancers of the skin, non-Hodgkin's lymphoma, Hodgkin's disease, leukaemia, liver cancer, and cancer of the cervix uteri.

As evaluated by the physician who conducted the social-psychiatric interview.

The age and sex adjusted Cox proportional-hazards regression analysis showed no significant association between extraversion and the risk of death from all causes among persons diagnosed with cancer (Table 3). After controlling for age at cancer diagnosis, sex, cancer site, clinical stage, smoking status, and alcohol consumption at baseline (in multivariable HR1), the effect of extraversion on risk of death was basically unchanged (HR, 0.8 (95% confidence intervals (CI)=0.4–1.7); Linear trend P=0.33). Adding psychiatric status as a confounder in HR2 did not change the result (Linear trend P=0.34). The multivariable adjusted HR3 was then estimated excluding 19 persons who were diagnosed as having cancer within the first 3 years from the baseline, but no differences in effect were observed for extraversion. The result when looking exclusively at cancer-related death in HR4 did not show any significant effect of extroversion (HR, 0.6 (95% CI=0.3–1.3); Linear trend P=0.12).
Table 3

Hazard ratios (HRs) and 95% confidence intervals (CIs) for risk of all-cause death according to extraversion and neuroticism in 189 persons diagnosed with cancer

  Extraversion
Linear trend testb
Neuroticism
Linear trend testa
  ⩽3 4–6 ⩾7 Linear P-value ⩽2 3–4 ⩾5 Linear P-value
Total subjects           
 No. of death/no. of subjects27/5929/7726/53  35/8122/5925/49  
 Median survival years495  595  
 Age and sex adjusted HR1.0 (referent)0.7 (0.4–1.2)1.0 (0.5–1.8)1.0 (0.9–1.1)0.611.0 (referent)0.9 (05–1.6)1.5 (0.9–2.6)1.1 (1.0–1.2)0.12
 Multivariable adjusted HR11.0 (referent)0.5 (0.3–1.0)0.8 (0.4–1.7)0.9 (0.8–1.1)0.331.0 (referent)1.2 (0.6–2.1)2.6 (1.4–5.0)1.2 (1.1–1.4)<0.01
 Multivariable adjusted HR21.0 (referent)0.6 (0.3–1.0)0.9 (0.4–1.7)0.9 (0.8–1.1)0.341.0 (referent)1.1 (0.6–2.1)2.3 (1.1–4.7)1.2 (1.0–1.3)0.04
 Multivariable adjusted HR31.0 (referent)0.6 (0.3–1.1)0.8 (0.4–1.7)1.0 (0.8–1.1)0.381.0 (referent)1.2 (0.6–2.2)2.6 (1.2–5.4)1.2 (1.0–1.3)0.02
 Multivariable adjusted HR41.0 (referent)0.5 (0.2–0.9)0.6 (0.3–1.3)0.9 (0.8–1.0)0.121.0 (referent)0.9 (0.4–1.7)2.2 (1.0–4.8)1.2 (1.0–1.4)0.04
           
Men
 No of death/total8/1213/2516/28  19/3611/187/11  
 Median survival years254  433  
 Multivariable adjusted HR11.0 (referent)1.3 (0.4–4.2)1.2 (0.4–4.0)1.0 (0.8–1.2_0.991.0 (referent)1.6 (0.6–4.3)2.2 (0.6–4.3)1.2 (1.0–1.2)0.08
 Multivariable adjusted HR21.0 (referent)1.1 (0.3–3.9)1.2 (0.4–4.1)1.0 (0.8–1.2)0.981.0 (referent)1.4 (0.5–4.3)1.8 (0.5–7.1)1.2 (0.9–1.5)0.17
           
Women
 No of death/total19/4716/5210/25  16/4511/4118/38  
 Median survival years7119  997  
 Multivariable adjusted HR11.0 (referent)0.5 (0.2–1.2)0.7 (0.3–1.9)0.9 (0.8–1.1)0.181.0 (referent)0.7 (0.3–2.0)3.4 (1.4–8.6)1.3 (1.1–1.5)<0.01
 MultivariableHR21.0 (referent)0.5 (0.2–1.2)0.7 (0.3–1.9)0.9 (0.8–1.1)0.181.0 (referent)0.7 (0.2–1.9)3.2 (1.1–8.7)1.2 (1.0–1.6)0.03

Multivariable HR1 was adjusted for age at cancer diagnosis (continuous variable), sex, cancer type (digestive organs, hormone-related organs, virus and immune-related organs, respiratory organs, or other organs), clinical stage (in situ, localised, regional invasion, distant metastasis, or unknown), smoking status at baseline (never smoker, past smoker, or current smoker), and alcohol consumption in grams per week at baseline (0, 1–150, or 151 or more).

Multivariable HR2 was adjusted for psychiatric status (normal, neurotic, or deviant/psychotic) in addition to variables adjusted for using multivariable HR1.

HR3 was estimated excluding 19 subjects who were diagnosed with cancer within the first 3 years from baseline and was adjusted for using the same variables as in multivariable HR2.

HR4 was estimated with cancer mortality as the end point and was adjusted for using the same variables as in multivariable HR2.

Linear trend tests were calculated by treating the personality subscales as continuous variables.

For neuroticism and the risk of deaths from all causes among persons diagnosed with cancer, the age and sex adjusted HR showed no significant association. The multivariable adjusted HR (HR1) showed a significant association between neuroticism and the risk of death from all causes (HR, 2.6 (1.4–5.0); Linear trend P<0.01)). When adding psychiatric status as a confounder the association remained significant. The multivariable adjusted HR3 was estimated excluding persons diagnosed as having cancer within the first 3 years from the baseline, but only small differences in effect were observed (Linear trend P=0.02). When using cancer mortality as the end point (case=69) in HR4, a similar, significant, linear, positive association between neuroticism and the risk of death was observed (Linear trend P=0.04). We furthermore conducted analyses stratified by sex. No significant association between extraversion and cancer survival was found among men and women. Among women, neuroticism was strongly associated with cancer survival in multivariable adjusted HR2 (Linear trend P=0.03), and the same pattern was observed among men although the estimates were not significant. Also, when including sex and neuroticism as an interaction term, the associations between neuroticism and the risk of death were not remarkably modified by sex (P>0.05). When stratifying according to 10-year age groups, cancer type, clinical stage, smoking, and alcohol consumption, the associations between neuroticism and the risk of cancer were not remarkably modified. Also, changing the cutoff points for the personality scales from tertiles to quartiles did not make any change in effect.

DISCUSSION

This population-based prospective cohort study in Denmark revealed a significant association between neuroticism and the risk of death from all causes as well as from cancer-related death among persons diagnosed with cancer. Stratification by gender suggested that the effect was stronger among women compared with men, but no gender-dependent effect modification on neuroticism and risk of death was observed. No significant association was found between extroversion and risk of death from all causes nor of cancer-related death. Five earlier studies investigated associations between personality traits using the Eysenck measurements and cancer survival. Nakaya followed up 890 cases of total cancer for 8 years and documented 356 deaths from all causes. No significant associations were found for extraversion, neuroticism, psychoticism, or lie. Ratcliffe followed-up 63 cases of Hodgkin's disease and non-Hodgkin's lymphoma for 5 years revealing 27 deaths from all causes. A positive significant, linear association was observed between lie and the risk of death from all causes (Linear trend P=0.001). Dean and Surtees (1989) followed up 121 postoperative cases of breast cancer for 6–8 years revealing 22 deaths from all causes. Extraversion, neuroticism, and lie showed no significant effect on cancer survival. Hislop followed-up 133 cases of breast cancer for 4 years revealing 26 deaths from all causes. A significant inverse association was observed between extraversion and the risk of death from all causes (multivariate HR=0.33, P<0.05). Neuroticism was not associated with risk of death (multivariate HR=0.85, P>0.05). Lastly, Greer followed-up 69 postoperative cases of breast cancer for 5 years revealing 18 deaths from all causes. No significant associations were found for extraversion and neuroticism. The results of the current study indicated that neuroticism was associated with cancer survival and this association was not observed in any of the previous studies, only associations between lie and extroversion and cancer survival was found (Hislop ; Ratcliffe ). The differences in the results found by the various studies could be a result of differences in methodological quality, or perhaps a chance finding. An association between neuroticism and cancer survival is theoretically possible and could be related to stress. Studies have found that neuroticism leads to a high level of psychological distress (De Jong ) and it is possible that stress, through a dysregulation of the immune system (Maddock and Pariante, 2001; Kiecolt-Glaser ), could result in a poor cancer prognosis. It is also possible that the association is related to depression. In an earlier study using a population-based sample, neuroticism was reported to be a significant risk factor for major depression (Kendler ). Furthermore, a number of prospective studies have reported a statistically significant association between depression (higher degree of depressive symptoms or psychiatrically diagnosed depression) and survival in patients with various types of cancer (Hjerl ; Goodwin ). The association between depression and cancer survival could be explained by potential intermediaries such as endocrinological or immunological pathways (Pettingale ; Kiecolt-Glaser and Glaser, 1999; Spiegel and Kato, 1996), or by compliance with cancer treatment (Holland, 1987; Colleoni ). Moreover, suicide is also thought to influence survival from cancer (Akechi ; Yousaf ). This study had several methodological advantages compared with previous studies on personality and cancer survival. First, the study to the best of our knowledge included the second highest number of cancer cases and deaths in all of the studies conducted until now, and analyses were conducted on both death from all causes and cancer-related deaths. Both measures were important; ideally cancer-related death should be more accurate, but errors might be introduced at the assignment of cause of death and generally the autopsy rate is low; for example, in 1996 the overall autopsy rate in Denmark was 12.5% (Juel and Helweg-Larsen, 1999). All-cause of death is thus in comparison to cancer-related death a broader, but more clear and simple end point. Second, we controlled extensively for potential confounding variables, including cigarette smoking and alcohol consumption. A number of studies have reported that smoking and alcohol consumption are associated with extraversion and other personality traits (Arai ) as well as with cancer survival (Tammemagi ). Comparing point estimates of the HRs for neuroticism in the univariate and multivariate analyses, we observed differences suggesting that smoking and alcohol did affect cancer survival (Table 2). Also, personality traits were assessed before the cancer diagnosis, and to the best of our knowledge this has only been performed in one previous study (Nakaya ). Assessing personality traits after the cancer diagnosis means that the assessment may have been influenced by the psychological reactions to the diagnosis or brought about by the treatment. To assess personality traits before the diagnosis may prevent this type of bias (Nakaya ). Our study also has some limitations. First, the number of persons diagnosed as having cancer in the current study population was small, especially among the men. One would prefer to stratify by cancer site since the treatment and prognosis differs for various cancer types. On the other hand, most of the studies, which in fact provided this kind of site-specific survival analyses were hampered by small numbers. The analyses may not have had sufficient statistical power to detect associations between small increases or decreases in the risk of death from all causes and personality traits. Also, the confidence limits in this study for the multivariable analyses on neuroticism among women were broad, and it is possible that the result was due to chance. Third, we had no information on health behaviours after the cancer diagnosis (Kuhn ) or on compliance with treatment, which may have affected survival. Lastly, we lack a detailed theoretical mechanism explaining why the association between neuroticism and cancer survival was mainly present among women. It is possible that the mechanism is connected to depression. In the current study, the association between neuroticism and cancer survival was stronger among women. Also, the risk of depression is higher among women compared with men (Kendler ). A potential explanation for the observed stronger association between neuroticism and cancer survival among women could thus be that high neuroticism involves an increased risk of depression, which may affect the risk of death. Evidence supporting this hypothesis in the current study is weak since we found no gender-related effect modification and no deaths were related to suicide. It would be highly relevant for future research to include measures of depression in order to shed light on whether depression can act as a mediating factor. In conclusion, the results from this population-based prospective cohort study in Denmark support the hypothesis that neuroticism is positively associated with cancer survival. Stratification by sex suggested that the effect was stronger among women compared with men, but no gender-related significant effect modification on neuroticism and risk of all cause or cancer-related death was observed. Further research on neuroticism and cancer survival within specific cancer types and including a large population is needed.
  28 in total

Review 1.  How does stress affect you? An overview of stress, immunity, depression and disease.

Authors:  C Maddock; C M Pariante
Journal:  Epidemiol Psichiatr Soc       Date:  2001 Jul-Sep

Review 2.  Psycho-oncology and cancer: psychoneuroimmunology and cancer.

Authors:  J K Kiecolt-Glaser; T F Robles; K L Heffner; T J Loving; R Glaser
Journal:  Ann Oncol       Date:  2002       Impact factor: 32.976

3.  Personality traits, health behavior, and risk for cancer: a prospective study of Swedish twin court.

Authors:  Pernille Envold Hansen; Birgitta Floderus; Kirsten Frederiksen; Christoffer Johansen
Journal:  Cancer       Date:  2005-03-01       Impact factor: 6.860

4.  The biological correlates of psychological responses to breast cancer.

Authors:  K W Pettingale; A Philalithis; D E Tee; H S Greer
Journal:  J Psychosom Res       Date:  1981       Impact factor: 3.006

5.  [The concept of representativity in epidemiological studies. Examples from population study of 40 year olds in Glostrup].

Authors:  H Hollnagel; H Saelan; K Garde; S Larsen
Journal:  Ugeskr Laeger       Date:  1981-07-06

6.  Managing depression in the patient with cancer.

Authors:  J C Holland
Journal:  CA Cancer J Clin       Date:  1987 Nov-Dec       Impact factor: 508.702

Review 7.  Evaluation and outcome of behavioural changes in the rehabilitation of cancer patients: a review.

Authors:  Katrin Gaardbo Kuhn; Ellen Boesen; Lone Ross; Christoffer Johansen
Journal:  Eur J Cancer       Date:  2005-01       Impact factor: 9.162

8.  Effect of depression on diagnosis, treatment, and survival of older women with breast cancer.

Authors:  James S Goodwin; Dong D Zhang; Glenn V Ostir
Journal:  J Am Geriatr Soc       Date:  2004-01       Impact factor: 5.562

9.  Cancer registration in Denmark and the study of multiple primary cancers, 1943-80.

Authors:  O M Jensen; H H Storm; H S Jensen
Journal:  Natl Cancer Inst Monogr       Date:  1985-12

10.  Depression as a prognostic factor for breast cancer mortality.

Authors:  Karen Hjerl; Elisabeth W Andersen; Niels Keiding; Henning T Mouridsen; Preben B Mortensen; Torben Jørgensen
Journal:  Psychosomatics       Date:  2003 Jan-Feb       Impact factor: 2.386

View more
  8 in total

1.  A case-control study of the association between psychosocial factors and the occurrence of laryngeal cancer.

Authors:  Chao Wang; Guoliang Fan; Rui Xu; Jingting Wang; Lina Wang; Lu Zhang; Qiuying Li
Journal:  Mol Clin Oncol       Date:  2017-07-25

2.  Personality traits, patient-centered health status and prognosis of brain tumor patients.

Authors:  Adomas Bunevicius
Journal:  J Neurooncol       Date:  2018-01-11       Impact factor: 4.130

3.  Anxiety and depression symptoms in the 2 years following diagnosis of breast or gynaecologic cancer: prevalence, course and determinants of outcome.

Authors:  Lesley Stafford; Fiona Judd; Penny Gibson; Angela Komiti; G Bruce Mann; Michael Quinn
Journal:  Support Care Cancer       Date:  2015-01-06       Impact factor: 3.603

Review 4.  Associations of social networks with cancer mortality: a meta-analysis.

Authors:  Martin Pinquart; Paul R Duberstein
Journal:  Crit Rev Oncol Hematol       Date:  2009-07-14       Impact factor: 6.312

Review 5.  Public health significance of neuroticism.

Authors:  Benjamin B Lahey
Journal:  Am Psychol       Date:  2009 May-Jun

6.  Personality Traits and Adaptive HIV Disease Management: Relationships with Engagement in Care and Condomless Anal Intercourse Among Highly Sexually Active Sexual Minority Men Living with HIV.

Authors:  Conall O'Cleirigh; Nicholas S Perry; S Wade Taylor; Jessica N Coleman; Paul T Costa; Kenneth H Mayer; Steven A Safren
Journal:  LGBT Health       Date:  2018-04-25       Impact factor: 4.151

7.  Differences in Eysenck's Personality Dimensions between a Group of Breast Cancer Survivors and the General Population.

Authors:  Francisco García-Torres; Rosario Castillo-Mayén
Journal:  Int J Environ Res Public Health       Date:  2019-04-08       Impact factor: 3.390

8.  Personality of outpatients with malignant tumors: a cross-sectional study.

Authors:  Zhuo Wang; Toshihiko Sakakibara; Yuichi Kasai
Journal:  World J Surg Oncol       Date:  2012-09-11       Impact factor: 2.754

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.